Guinea-Bissau vs Moldova: Antiretroviral therapy coverage for PMTCT
Guinea-Bissau
79.0%
in 2024
Moldova
79.0%
in 2024
Guinea-Bissau rank
43rd
Moldova rank
43rd
Antiretroviral therapy coverage for PMTCT over time
- Guinea-Bissau
- Moldova
How they compare
Guinea-Bissau currently reports 79.0% against 79.0% in Moldova, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Moldova ahead.
Guinea-Bissau ranks 43rd and Moldova ranks 43rd of 84 countries.
Across the 3 decades both report, Guinea-Bissau averaged higher in 1 and Moldova in 2.
Head to head by decade
| Decade | Guinea-Bissau | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.1% | 17.9% | 14.8% | Moldova |
| 2010s | 64.7% | 62.8% | 1.9% | Guinea-Bissau |
| 2020s | 68.6% | 81.4% | 12.8% | Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Guinea-Bissau or Moldova?
- Guinea-Bissau, at 79.0% against 79.0% in Moldova as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Guinea-Bissau and Moldova?
- 0.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Moldova?
- 25 years are reported by both, from 2000 to 2024.
- How do Guinea-Bissau and Moldova rank globally for antiretroviral therapy coverage for pmtct?
- Guinea-Bissau ranks 43rd and Moldova ranks 43rd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).